👍 Two Small-Cap Dividend Plays for Your Portfolio Now

Markets continue to be sensitive to the coronavirus outbreak. As news of a second potential case in the United States broke, so did markets, leading to the first 1 percent intra-day decline for stocks in months, but at least they closed off their intra-day lows.
You're receiving this email because you are subscribed to Trading Tips,
if you no longer wish to receive these emails you can unsubscribe here.
Good morning. Markets continue to be sensitive to the coronavirus outbreak. As news of a second potential case in the United States broke, so did markets, leading to the first 1 percent intra-day decline for stocks in months, but at least they closed off their intra-day lows.

With a viral outbreak likely to weigh on economic activity in travel and tourism, expect airline and casino companies to be hard-hit for now, but a potential buying opportunity later. In the meantime, the only asset that seems to consistently rise on these outbreaks is gold as a safe-haven play from market chaos.

Sponsored Content
The NEW biggest-selling drug of all time. How to profit
If you're looking to double your money and potentially make 1,000% in gains, then you NEED this biotech stock.

This company has discovered a revolutionary breakthrough in treating heart disease that may end heart attacks and strokes FOREVER! Global demand is skyrocketing and estimated annual sales are a staggering $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, expect the stock price to double in a matter of days.

Get onboard BEFORE the big FDA announcement. Access your FREE report here.

MARKETS
DOW 28,989.73 -0.58%
S&P 3,295.47 -0.90%
NASDAQ 9,314.91 -0.93%
*As of market close
Stocks closed near their lows of the day going into the weekend, as the coronavirus outbreak continued.
Oil dropped 2.1 percent, closing at $54.39 per barrel.
Gold rose 0.36 percent, moving to $1,571 per ounce.
Cryptocurrencies traded mixed, with Bitcoin rising 1 percent to $8,489.

Today's TOP TIPS
Two Small-Cap Dividend Plays for Your Portfolio Now
We're fans of dividend paying companies. There's nothing as satisfying as getting regular cash payments, especially during those periods of market uncertainty.

What's more, dividend paying companies are usually more financially conservative, focusing on managing their existing business rather than on growth. While that may scare off growth investors, it doesn't need to.

There are plenty of small-cap plays can offer growth as well as current income now, which makes them attractive bargains in today's environment.

» FULL STORY

Insider Trading Reports: Dow Inc (DOW)
Richard Davis, a director at Dow Inc (DOW), added 6,000 shares to his holdings. The buy increased his stake by 82 percent. The total cost of the buy came to just over $317,000.

Insider buying data for the past few years shows a mix of buys and sells, with total share buys exceeding sales. Most activity has occurred by directors.

Dow Inc is one of three companies spun off from DowDuPont in April 2019.

» FULL STORY

Unusual Options Activity: Juniper Networks (JNPR)
March 2020 $23 put options on Juniper Networks (JNPR) saw a 50-fold surge in volume, going from 123 open contracts to over 5,900 trade hands.

The trade, expiring in 53 days, is a bet that shares of the company will fall at least $1.50 from their current price.

For the trader to profit at expiration, shares would need to close in on $22.65, to make up for the cost of $0.45 per contract.

» FULL STORY

IN OTHER NEWS
In China, the rampaging coronavirus shuts down Shanghai Disneyland.
McDonald's closes down locations in five cities as well.
Facebook faces more scrutiny in Europe over transparency.
U.S. business activity picks up, while European business activity slows down to start the year.
U.S. lenders extended $2.4 trillion in home loans last year, the highest since 2006.
The former CEO of Wells Fargo is fined $17.5 million and banned from the banking industry.
HP considers a large share buyback as an alternative to Xerox's attempted hostile takeover.
In earnings, Intel beats and raises its full-year guidance.
American Express beats on a 12 percent jump in profit from the previous year.
Atlassian shares rally following a substantial earnings beat.

S&P 500 MOVERS
TOP
INTC 8.133%
ANET 3.473%
DVA 3.342%
AXP 2.847%
APD 2.807%
BOTTOM
DFS 11.136%
SYF 9.862%
AAP 5.376%
SWKS 4.587%
ORVO 4.457%

Quote of the Day
I think America picked the war to fight with China … at really the wrong time. They should have picked the war 10 years ago. Today, China has 1.4 billion people — the world's second largest economy. Who's going to consume more McDonald's and Coca-Cola than China?
- Hong Kong property developer Tan Sri Dato' David Chiu, chairman of Far East Consortium International, on the fragile phase one trade deal between the United States and China, and why the deal may still fall through in the future.

Sponsored Content
Get in before FDA approval for 10X  gains
This could be the biggest health breakthrough of the decade. FDA approval for a blockbuster new cholesterol drug is just around the corner.

FDA approval can be like rocket fuel for biotech stocks. We've seen stock prices soar 117%, 368%, 626%, 1,100% in mere days. But sadly, most investors don't find out about these huge breakthroughs until AFTER the FDA announces approval.

Most media outlets have yet to report on this life-changing drug breakthrough that could end heart disease and death. Their first story most likely will be the FDA announcement. That's far too late for investors to rack up amazing double-your-money gains.

I have a FREE Special Report on this once-in-a-lifetime opportunity. Investors who act before news of FDA approval could reap windfall profits. This could be the biggest biotech story of 2020. Get the full details here.

 
Not sure the best way to get started?
Follow these simple steps to hit the ground running.

› Step #1 - Get These FREE Reports:

Warren Buffett's Top 5 Stocks | 10 Great Stocks Under $10 |
7 High Yield Dividend Stocks
 

› Step #2 - Join Our Premium Advisories:

The Next Superstock | Triple Digit Returns | Options Cash Cow
 

› Step #3 - Connect With The Community:

Trading Tips Official Facebook Group

       
 

Nothing in this email should be considered personalized financial advice. ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.

By reading this communication, you agree to the terms of this disclaimer, including, but not limited to: releasing The Company, its affiliates, assigns and successors from any and all liability, damages, and injury from the information contained in this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.

As defined in the United States Securities Act of 1933 Section 27(a), as amended in the Securities Exchange Act of 1934 Section 21(e), statements in this communication which are not purely historical are forward-looking statements and include statements regarding beliefs, plans, intent, predictions or other statements of future tense.

Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell securities. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.



 
 

This email was sent to phanphuongthanh89.822152@blogger.com by editor@tradingtips.com

TradingTips.com | 3435 Ocean Park Blvd. Suite 107-334 Santa Monica, CA 90405

Manage Subscriptionsreport SPAM


 

No comments:

Post a Comment